ArticleJournal for immunotherapy of cancer2026
LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.
Mei Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.